' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Heparin Differentially Impacts Gene Expression of Stromal Cells from Various Tissues.
Laner-Plamberger, S; Oeller, M; Poupardin, R; Krisch, L; Hochmann, S; Kalathur, R; Pachler, K; Kreutzer, C; Erdmann, G; Rohde, E; Strunk, D; Schallmoser, K;
Sci Rep. 2019; 9(1):7258
Originalarbeiten (Zeitschrift)


Hochmann Sarah
Kalathur Ravi
Kreutzer Christina
Krisch Linda
Laner-Plamberger Sandra
Öller Michaela
Pachler Karin
Poupardin Rodolphe
Rohde Eva
Schallmoser Katharina
Strunk Dirk


Pooled human platelet lysate (pHPL) is increasingly used as replacement of animal serum for manufacturing of stromal cell therapeutics. Porcine heparin is commonly applied to avoid clotting of pHPL-supplemented medium but the influence of heparin on cell behavior is still unclear. Aim of this study was to investigate cellular uptake of heparin by fluoresceinamine-labeling and its impact on expression of genes, proteins and function of human stromal cells derived from bone marrow (BM), umbilical cord (UC) and white adipose tissue (WAT). Cells were isolated and propagated using various pHPL-supplemented media with or without heparin. Flow cytometry and immunocytochemistry showed differential cellular internalization and lysosomal accumulation of heparin. Transcriptome profiling revealed regulation of distinct gene sets by heparin including signaling cascades involved in proliferation, cell adhesion, apoptosis, inflammation and angiogenesis, depending on stromal cell origin. The influence of heparin on the WNT, PDGF, NOTCH and TGFbeta signaling pathways was further analyzed by a bead-based western blot revealing most alterations in BM-derived stromal cells. Despite these observations heparin had no substantial effect on long-term proliferation and in vitro tri-lineage differentiation of stromal cells, indicating compatibility for clinically applied cell products.